🇺🇸 FDA
Pipeline program

preoperative short-course radiotherapy

pSRT-201106

Phase 3 other terminated

Quick answer

preoperative short-course radiotherapy for Rectal Neoplasms is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Rectal Neoplasms
Phase
Phase 3
Modality
other
Status
terminated

Clinical trials